Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment
Author:
Funder
NIH/NCI
CPRIT
Breast Cancer Research Foundation
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference57 articles.
1. Evaluation of targeted therapies in advanced breast cancer: the need for large-scale molecular screening and transformative clinical trial designs;Fadoukhair;Oncogene,2016
2. Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer;Schiavon;Sci Transl Med,2015
3. Breast Cancer, Version 1.2016;Gradishar;J Natl Compr Cancer Netw,2015
4. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials;Early Breast Cancer Trialists’ Collaborative;Lancet,2015
5. Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis;Yardley;Adv Ther,2013
Cited by 124 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advances in Breast Cancer Drug Discovery: A Review of Therapeutic Strategies and Studies Involving Photosensitizers, Caged Xanthones and Thiosemicarbazones Derivatives;Journal of the Brazilian Chemical Society;2024
2. Machine learning applications in cancer genomics;Machine Learning and Artificial Intelligence in Radiation Oncology;2024
3. Comparison of human epidermal growth factor receptor 2 and cancer stem cell markers like CD44 and CD133 expressions with clinicopathological parameters in gastric cancer;The European Research Journal;2023-09-04
4. Characterizing excision repair cross-complementing family genes as drug resistance biomarkers in breast cancer;Beni-Suef University Journal of Basic and Applied Sciences;2023-08-30
5. Clinical application and pharmacological mechanism of polyherbal phytoformulations in breast cancer and depression treatment: review and network pharmacological analysis;Proceedings of the Indian National Science Academy;2023-08-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3